2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$266.00+$1.04 (+0.39%)
Price as of Aug 21, 2026 7:59 PM EDT- $468.2BMarket Cap
- 29.72%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$266.00+$1.04 (+0.39%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $264.96 | ||
Change | +$3.13 (+1.20%) | ||
Open | $260.70 | ||
High | $266.84 | ||
Low | $260.10 | ||
Previous Close | $261.83 | ||
Volume | 5,156,808 | ||
30-Day Average Volume | 5,323,298 | ||
1-Week Change | 6.21% | ||
1-Month Change | 3.46% | ||
1-Year Change | 29.72% | ||
3-Year Change | 95.71% | ||
5-Year Change | 167.91% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $135.1B | ||
Market Cap | $468.2B | ||
Enterprise Value | $532.5B | ||
Period: QTR TTM FY | |||
Revenue | $17.0B | ||
Net Income | $3.6B | ||
Free Cash Flow | $3.1B | ||
EBIT | $5.0B | ||
EBITDA | $6.6B | ||
Net Working Capital | -$8.0B | ||
EPS | $2.03 | ||
Enterprise Value/EBITDA | 80 | ||
Enterprise Value/Revenue | 31 | ||
P/B | -79 | ||
P/E | 131 | ||
PEG | 0 | ||
Price/Free Cash Flow | 150 | ||
Price/Operating Cash Flow | 136 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.61% | ||
Trailing Annual Dividend Yield | 2.58% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield